Profile, a personalized medicine cancer research project launched by scientists at Dana-Farber/Brigham and Women's Cancer Center and Dana-Farber/Boston Children's Cancer and Blood Disorders Center, is one of the nation's most comprehensive precision
cancer medicine initiatives. Profile is a large-scale cohort research study aimed at collecting as much information and genomic data as possible for every type of cancer. The goal is to use this data to learn more about the genetic and molecular
alterations that cause cancer to develop and progress. Researchers will use that information to develop better ways to treat cancer and strategies for preventing it.
Profile aims to detect genetic alterations in tumors and potentially identify targeted therapies that are most likely to be effective in individual patients. The database of tumor genomic profiling data derived from a very large number of patients
linked to clinical information makes Profile a powerful tool for discovery and personalized cancer medicine. This database, which adheres to emerging IT standards, will also support proposals for new research studies and clinical trials.
To accommodate this constantly evolving field, the study's platform is designed to scale up to include additional screening for new mutations as they are discovered. Germline genotyping is expected in the future. Whole exome sequencing and then whole
genome sequencing will also become part of this program.
Learn more about Profile
Learn more about precision cancer medicine
CCGD: Aaron ThornerProfile: Elizabeth GarciaBioinformatics: Matthew Ducar
For general questions:617-582-7253 email@example.com